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1230Objectives: To determine whether a cardiac diagnosis is a predictor of neurodevelopmental outcomes after in-
fant cardiac surgery.
Methods: Infants with ventricular septal defect (VSD), tetralogy of Fallot (TOF), transposition of the great
arteries (TGA), and hypoplastic left heart syndrome (HLHS) in a study of apolipoprotein E (APOE) polymor-
phisms, and neurodevelopmental outcome underwent neurodevelopmental and genetic evaluation at 4 years of
age. The domains tested included cognition, language, speech, memory, executive function, visual-motor, fine
motor, and reading and math skills.
Results: Testing was completed in 178 patients with normal genetic evaluations: VSD (n ¼ 26), TOF (n ¼ 44),
TGA (n ¼ 41), and HLHS (n ¼ 67). No differences were found in gestational age, ethnicity, APOE genotype,
socioeconomic status, or maternal education among groups. Patient age at the first surgery was significantly
lower for patients with TGA and HLHS compared with those with TOF and VSD. The postoperative length
of stay was significantly longer for HLHS than all other groups and for TGA compared with TOF and VSD.
HLHS correlated significantly with the use of deep hypothermic circulatory arrest and multiple operations.
The mean scores for each domain were within normal limits for all groups. Compared with the other patients,
those with HLHS had significantly lower scores for cognition, fine motor skills, executive function, and math
skills. No significant differences were found among the TGA, TOF or VSD patients for any domain. Significant
impairments in at least 1 domain were identified in 8% (2/25) of patients with VSD, 20% (8/41) with TOF, 17%
(7/41) with TGA, and 18% (12/65) with HLHS. After correction for the demographic, preoperative, and oper-
ative variables, no significant differences were found among the groups for any domain.
Conclusions: The mean scores for the neurodevelopmental outcomes domains tested were in the normal range
for preschool children with no recognized genetic syndromes after surgery for VSD, TOF, TGA, and HLHS. In
each diagnostic group, the number of children with impairments in at least 1 domain increased compared with
the general population. Unadjusted neurodevelopmental outcomes for HLHS were lower for cognition, fine mo-
tor skills, executive function, and math skills compared with the other patients. After correction for the demo-
graphic, preoperative, and operative variables, no significant differences were found among the groups for any
domain. The specific cardiac diagnosis determines a large portion of the variation in these covariates. Therefore,
although HLHS did predict for poorer outcomes in some domains, it did not add predictive power to the other
factors considered. (J Thorac Cardiovasc Surg 2010;140:1230-7)Congenital heart defects (CHDs) are the most common
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The Journal of Thoracic and Cardiovascular Sur40,000 children annually in the United States) with one
third of the affected children requiring intervention in early
infancy. Improved survival, combined with the expectations
for independence and behavioral self-regulation as the chil-
dren mature, has led to a growing recognition of neurobeha-
vioral symptoms and impaired functional outcomes in some
survivors. Neurodevelopmental dysfunction is the most
common, and potentially most disabling, outcome of
CHDs and their treatment.1,2
The prevalence of adverse neurodevelopmental out-
comes appears to vary according to the cardiac diagnosis.
Previous studies have suggested that infants with transposi-
tion of the great arteries (TGA) undergoing the arterial
switch tend to have better short- and intermediate-term neu-
rodevelopmental outcomes compared with infants with
other types of CHD suitable for 2-ventricle repair, such asgery c December 2010
Abbreviations and Acronyms
APOE ¼ apolipoprotein E
CPB ¼ cardiopulmonary bypass
CHD ¼ congenital heart defect
DHCA ¼ deep hypothermic circulatory arrest
GFTA ¼ Goldman Fristoe Test of Articulation 2
HLHS ¼ hypoplastic left heart syndrome
ND ¼ neurodevelopmental
NEPSY ¼ Neuro-PSYchology Statue test
TGA ¼ transposition of great arteries
TOF ¼ tetralogy of Fallot
VMI ¼ visual motor integration
VSD ¼ ventricular septal defect
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(VSD).3 Many studies have suggested that infants with
functional single ventricle, especially hypoplastic left heart
syndrome (HLHS), have a greater prevalence of adverse
neurodevelopmental outcomes compared infants with other
types of CHD.4,5 However, it is unclear whether these
differences in outcomes result from differences in central
nervous system development related to the type of CHD,
differences in the physiologic effects of the specific
defect, or diagnosis-specific differences in management.
Apolipoprotein E (APOE) is an important regulator of
cholesterol metabolism and has an important role as a sus-
ceptibility gene that modifies the outcome after central ner-
vous system injury. In 1998, we initiated a prospective study
evaluating the association between neurodevelopmental
dysfunction and the APOE genotype in 550 neonates and in-
fants undergoing surgery for CHD.6 The APOE 32 allele
was associated with a significantly worse neurodevelop-
mental outcome, including cognitive function and motor
skills, at 1 year of age. The cohort subsequently underwent
a detailed neurobehavioral evaluation at 4 to 5 years of age
to test the hypothesis that the APOE genotype predicts the
susceptibility for long-term neurodevelopmental dysfunc-
tion after cardiac surgery in infants. The risk of behavioral
problems was modified by the APOE genotype. The APOE
32 allele was associated with increased behavior problems,
impaired social interactions, and restricted behavior pat-
terns.7 An additional aim of the evaluation was to evaluate
the significance of cardiac diagnosis as an independent risk
factor for adverse neurodevelopmental outcomes.MATERIALS AND METHODS
The present study was a prospective trial evaluating the association be-
tween neurodevelopmental dysfunction and cardiac diagnosis in preschool
patients (4-5 years of age) after cardiac surgery in infancy.6,7 Patients 6
months of age or younger undergoing surgery for CHD using
cardiopulmonary bypass (CPB) with or without deep hypothermic
circulatory arrest (DHCA) were eligible. The exclusion criteria includedThe Journal of Thoracic and Carmultiple congenital anomalies, a recognizable genetic or phenotypic
syndrome other than chromosome 22q11 microdeletion syndrome, and
language other than English spoken in the home. The Institutional
Review Board at The Children’s Hospital of Philadelphia approved the
study, and the parent or guardian provided informed consent.
The population for the present study consisted of patients with TGA,
TOF, VSD, or HLHS who returned for the evaluation and had normal
genetic evaluation findings.
Operative Management
Alpha-stat blood gas management was used. The pump flow rates were
not standardized for the present study. DHCAwas used at the surgeon’s dis-
cretion. Before DHCA, patients underwent core cooling, with topical hypo-
thermia of the head to a nasopharyngeal temperature of 18C. Modified
ultrafiltration was performed in all patients.
Data Collection
Preoperative factors that might independently affect the neurobehavioral
outcomes, including gestational age, birth head circumference, and birth
weight,were obtained from the hospital records.Theweight and age at surgery
were recorded for the initial surgery and subsequent procedureswithCPB.The
operative variables were recorded, including the duration of CPB and DHCA,
lowest nasopharyngeal temperature, and hematocrit after hemodilution.
Four-Year Neurodevelopmental Examination
The neurodevelopmental evaluation was performed between the fourth
and fifth birthdays. The growth measurements (ie, weight, length, and head
circumference) were recorded. The maternal education, Hollingshead so-
cioeconomic status, and ethnicity were determined by parental report.
A health history was obtained focusing on the incidence of interim illness:
rehospitalizations, neurologic events or interim evaluations, current medi-
cations, and parental concerns about health.
Patients were evaluated by a genetic dysmorphologist at the 1 and/or 4
year evaluations. Additional genetic analyses were performed if indicated.
Neonatal recognition of the dysmorphic features can be difficult; therefore,
some patients were enrolled for whom the diagnosis of a genetic syndrome
was not made until a later evaluation. Patients were classified as having no
definite genetic syndrome or chromosomal abnormality (normal), sus-
pected genetic syndrome (suspect), or definite genetic or chromosomal
abnormality (abnormal). Only patients classified as normal were included
in the present analysis.
APOE Genotype Determination
Whole blood or a buccal swab was obtained before the operation and
stored at 4C. Genomic DNA was prepared and used to determine the
APOE genotypes using a previously published method.6
Neurodevelopmental Testing
To provide a broad assessment of neurodevelopmental status, multiple
domains were tested, including cognition, language, speech, memory, ex-
ecutive function, and visual-motor, fine motor, and academic skills. Cogni-
tive skills were assessed using the full-scale IQ from the Wechsler
Preschool and Primary Scale of Intelligence, 3rd edition (WPPSI-III).8
Core language skill was assessed using the Preschool Language Scale-4
Total Language Score (PLS-4 TLS).9 Executive function was assessed us-
ing the Neuro-PSYchology statue test, which targets inhibition and motor
persistence (component processes of attention and executive function).10
Visual-motor integration was assessed with the developmental test of
Visual Motor Integration, a simple copying task that assesses the child’s
fine motor and visual motor coordination skills.11 Speech production was
assessed using the Goldman Fristoe Test of Articulation 2 (GFTA).12
Academic achievement (school readiness for reading and math) was testeddiovascular Surgery c Volume 140, Number 6 1231
TABLE 1. Comparison of baseline and operative characteristics by diagnosis
Baseline characteristic TGA (n ¼ 41) TOF (n ¼ 44) VSD (n ¼ 26) HLHS (n ¼ 67) P value
Gender
Female 15 23 10 27
Male 26 21 16 40
Ethnicity
Asian-Pacific, Hispanic, Native American, or other 8 7 2 5
Non-Hispanic black 5 8 5 13
Non-Hispanic white 28 29 19 49
Gestational age (wk) n ¼ 41 n ¼ 44 n ¼ 26 n ¼ 67
Mean  SD (n) 39.1  1.6 35.5  1.9 38.6  2.0 38.6  1.6
Birth weight (g) n ¼ 41 n ¼ 44 n ¼ 26 n ¼ 67 .049*
Mean  SD (n) 3284  486 3055  568 3225  678 3275  593
Birth head circumference (cm) n ¼ 41 n ¼ 42 n ¼ 25 n ¼ 67
Mean  SD 33.8  1.4 33.6  2.0 33.4  1.9 34.1  1.9
Preoperative intubation (n) 20 (49%) 1 (2%) 0 (0%) 29 (43%) < .001y
Operative characteristics (first procedure)
Age (d) 4.7  5.4 90.7  50.8 102  37 4.7  4.7 < .001y
Weight (kg) 3.4  0.5 5.1  1.4 4.8  1.1 3.3  0.6 < .001y
Total CPB time (min) 114.3  55.5 59.5  21.1 45.8  16.3 55.4  27.8 < .001y
Use of DHCA 12/41 (29%) 10/44 (23%) 5/26 (19%) 67/67 (100%)
Total DHCA time (min) 10.3  18.2 6.1  13.1 6.0  14.2 44.3  16.0 < .001y
Hematocrit (%) after hemodilution 28.5  3.9 25.5  3.8 28.1  4.0 28.8  4.1 < .001y
Postoperative length of stay (d) 10.0  5.3 6.3  6.5 3.2  1.0 15.0  10.8 < .001y; .004z
No. of additional operations before 4-y evaluation 0.05  0.2 0.11  0.4 0 2.1  0.5 < .001y
Data presented as mean standard deviation or n (%). TGA, Transposition of great arteries; TOF, tetralogy of Fallot; VSD, ventricular septal defect;HLHS, hypoplastic left heart
syndrome; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest. *TGA versus TOF. yHLHS versus others, TGA versus TOF, TGA versus VSD. zTGA
versus TOF.
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dardized achievement test for children from 2 years to adulthood.13 Fine
motor skills were tested using theWide Range Assessment of Visual Motor
Abilities pegboard, a manipulative dexterity test.14 All the instruments, ex-
cept for the GFTA, have an expectedmean of 100, with a standard deviation
(SD) of 15. The GFTA is scored as a standard percentile ranking according
to the number of articulation errors. For all the tests, except the GFTA,
moderate impairment was defined as a score of 1 SD and 2 SD less than
the expected mean. Severe impairment was defined as a score more than
2 SDs less than the expected mean. In the normative population, approxi-
mately 14% will have a score greater than 1 SD less than the mean and ap-
proximately 2.5% will score more than 2 SDs less than the mean. For the
GFTA, impairment was defined as a score of 15th percentile or less. Not
every child was able to complete every test. If a child was judged to be
too developmentally impaired to complete the tasks, a score was imputed
by assigning them the lowest possible score for the specific test. If the child
was unable to complete the task for other reasons, the child was excluded
from the analysis for that domain. Additional details concerning the spe-
cific tests are provided in the Appendix.Statistical Analysis
The APOE genotype was coded for the presence of the 32 or 34 allele.
Subjects with the 3234 genotype (n ¼ 14) were excluded from the analysis
of the APOE genotype effect. The subjects were categorized into 3 groups:
32 (3232 and 3233), 33 (3333), and 34 (3334 and 3434). APOE group was
coded as a dummy variable, with group 33 as the reference. We tested
for differences in the variable distributions between HLHS and all other di-
agnoses and pairwise between TGA and TOF or VSD using a t test or
Fisher’s exact test. We tested for the association between the diagnosis
class and the neurodevelopmental outcomes using the unadjusted and a se-
ries of adjusted models. Models incorporating the diagnosis class coded as1232 The Journal of Thoracic and Cardiovascular Sureither HLHS versus all others or for pairwise differences between TGA and
TOF or VSD were tested against the same model with the diagnosis class
omitted, and the resulting analysis of variance P values are reported. We
used 4 adjusted models corresponding to the inclusion of preoperative vari-
ables (e.g., ethnicity, gender, socioeconomic class, mother’s education,
gestational age, birth weight, birth head circumference, intubation, and pre-
operative length of stay), operative variables (eg, age at surgery, weight at
surgery, total CPB time, total DHCA time, use of DHCA, hematocrit, ex-
tracorporeal membrane oxygenation/left ventricular assist device, delayed
sternal closure, and postoperative length of stay), interval variables (total
number of operations, total CPB time, total DHCA time, and use of
DHCA during the total interval), and a fully adjusted model combining
all variables from the other 3 models.
RESULTS
Between September 1998 andApril 2003, 675 eligible in-
fants underwent cardiac surgery. Of the 675 eligible infants,
23 had died before consent, the parents of 102 declined par-
ticipation, and 550 (81%) were enrolled. A total of 21
deaths occurred during the initial hospitalization, and an ad-
ditional 43 patients died before 5 years of age. The study
population was 65%white, 23% black, and 12% other eth-
nic origins; 58% were male. The largest diagnostic groups
were HLHS (n¼ 121), TOF (n¼ 83), VSD with or without
coarctation (n¼ 77), and TGA (n¼ 45). APOE genotyping
was completed in 540 (98%) of 550. The APOE genotype
distribution was e2e2 in 3, e2e3 in 64, e2e4 in 14, e3e3 in
323, e3e4 in 124, and e4e4 in 12 and was not different
from the Hardy-Weinberg proportions.gery c December 2010
TABLE 2. Unadjusted outcomes
P values
Domain All patients HLHS TGA TOF VSD
HLHS versus
others
TGA versus
TOF
TGAversus
VSD
Cognition 100.3  17.2 94.9  16.3 105.0  11.9 103.0  20.4 102.0  17.8 .001 .579 .443
Total language 102.2  15.0 99.7  14.6 103.9  11.7 103.4  18.8 104.2  13.6 .078 .873 .918
Visual-motor integration 96.6  16.0 94.0  15.7 98.7  13.5 98.0  17.7 97.8  17.3 .085 .825 .825
Speech production 49.4  29.7 50.2  30.3 46.4  28.9 51.3  32.4 48.7  26.2 .765 .466 .735
Reading skills 108.8  17.0 107.9  15.8 108.9  17.6 109.9  20.9 108.8  11.3 .611 .812 .979
Math skills 100.7  18.7 96.9  18.2 105.1  15.0 100.4  22.3 104.3  17.5 .037 .265 .856
Executive function 101.8  13.6 97.7  14.0 102.7  10.7 106.7  14.3 103  13.1 .002 .163 .851
Memory 96.6  14.8 94.4  14.2 98.3  13.4 97.1  16.8 98.9  15.1 .120 .709 .882
Fine motor 98.4  15.9 94.1  15.0 102.3  11.1 99.7  17.9 101.1  19.1 .004 .418 .761
Data presented as mean  standard deviation. Abbreviations as in Table 1.
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DA total of 486 patients were alive and eligible for the 4-
year evaluation, which was completed by 381 patients
(78% of those eligible). The baseline characteristics have
been previously reported for the patients returning for the
4-year evaluation (n ¼ 381), those who did not return
(n ¼ 105), and those who died before 4 years old
(n ¼ 64).7 The only significant difference in the baseline
characteristics between the returning and nonreturning
patients was underrepresentation of blacks in the returning
patients (21% versus 29%).
Of the 381 patients who returned at 4 years, 178 met the
entry criteria for the present study: HLHS (n ¼ 67), TGA
(n ¼ 41), TOF (n ¼ 44), and VSD (n ¼ 26). No differencesFIGURE 1. A,Mean neurodevelopmental outcome scores for all domains
except speech production. All normal scores 100 15. B, Mean percentile
score for speech production.
The Journal of Thoracic and Carwere found among the diagnostic groups for gender, ethnic-
ity, gestational age, APOE genotype, maternal education, or
socioeconomic status. Significant differences were identi-
fied among the diagnostic groups for several baseline and
operative management variables (Table 1). The birth weight
was lower for the patients with TOF. The use of preopera-
tive mechanical ventilation was more common in patients
with TGA and HLHS compared with those with TOF and
VSD. The patients with TGA and HLHS underwent their
initial operations in the newborn period. In general, the pa-
tients with TOF and VSD were older at the initial surgery.
The weight at surgery was greater for those with TOF and
VSD. The duration of CPB at the first surgery was greater
for those with TGA. Both the use and the duration of
DHCAwere greater for patients with HLHS. The postoper-
ative hospital length of stay was longer for thosewith HLHS
and TGA than for those with TOF or VSD.
All patients with HLHS underwent additional operations
with CPB before the 4-year evaluation. Additional opera-
tions with CPB were performed in 4 of the patients with
TOF, 2 with TGA, and in none of those with VSD. Also,
55 patients with HLHS underwent additional episodes of
DHCA, with a mean total duration of 50  23 minutes.
DHCAwas used in 1 patient with TOF and in none of those
with TGA or VSD.Neurodevelopmental Testing
The mean unadjusted scores for each domain are listed in
Table 2. The mean scores for each diagnostic group were
within 1 SD of the expected mean (Figure 1). In general,
the mean scores for the patients with HLHS tended to be
lower than the other diagnostic groups. Compared with
the other patients, those with HLHS had significantly lower
scores for cognition, fine motor skills, executive function,
and math skills. Using pairwise comparison, no significant
differences were found between the patients with TGA and
either TOF or VSD for any domain. In general, moderate
impairments in at least 1 neurodevelopmental (ND) domaindiovascular Surgery c Volume 140, Number 6 1233
TABLE 3. Severity of impairment
Moderate impairment (1-2 SD less than mean) Severe impairment (>1 SD less than mean)
Domain HLHS TGA TOF VSD HLHS TGA TOF VSD
Cognition 18/67 (27) 3/41 (7) 5/44 (11) 4/26 (15) 3/67 (4) 0/41 (0) 4/44 (9) 1/26 (4)
Total language 6/66 (9) 1/41 (2) 5/44 (11) 3/25 (12) 4/66 (6) 0/41 (0) 2/44 (5) 0/25 (0)
Visual-motor integration 13/67 (19) 2/41 (5) 5/44 (11) 5/26 (19) 6/67 (9) 1/41 (2) 4/44 (9) 1/26 (4)
Speech 12/65 (18) 7/41 (17) 8/41 (20) 2/25 (8)
Reading 5/66 (8) 4/41 (10) 3/43 (7) 0/23 (0) 0/66 (0) 0/41 (0) 0/43 (0) 0/23 (0)
Math 9/66 (14) 1/39 (3) 4/42 (10) 2/24 (8) 6/66 (9) 1/39 (3) 4/42 (10) 1/24 (4)
Executive function 16/66 (24) 2/41 (5) 5/40 (13) 1/25 (4) 1/66 (2) 0/41 (0) 0/40 (0) 2/25 (8)
Memory 9/64 (14) 3/41 (7) 6/40 (15) 2/24 (8) 5/64 (8) 3/41 (7) 3/40 (8) 2/24 (8)
Fine motor 12/67 (18) 2/41 (5) 5/43 (12) 2/26 (8) 7/67 (10) 0/41 (0) 3/43 (7) 2/26 (8)
Data in parentheses are percentages. Abbreviations as in Table 1.
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occurred in all diagnostic groups (Table 3). After correction
for the demographic, preoperative, and operative variables,
no significant differences were found among the groups for
any domain, including the contrast of HLHS to all other
groups (Table 4).DISCUSSION
ND dysfunction has been increasingly recognized as an
important complication of cardiac surgery performed in in-
fancy. We have previously shown that patient-specific fac-
tors, such as recognized genetic syndromes and genetic
polymorphisms, which modify the brain’s response to in-
jury, are significant modulators of the risk of an adverse
ND outcome.6,7,15 It is known that ND outcomes vary
among patients with different cardiac defects. In
particular, the outcomes for infants with a functional
single ventricle, especially HLHS, had a greater
prevalence of adverse ND outcomes compared infants
with other types of CHD.4,5,16 In general, the reported
outcomes for infants with TGA have been superior those
with other types of 2-ventricle CHD.3 It is not known
whether these differences in ND outcomes result from dif-TABLE 4. Association between HLHS and other diagnoses and
neurodevelopmental outcomes using adjusted models
Analysis of variance P value
Domain
Preoperative
covariates
Operative
covariates
Interval
covariates
All
covariates
Cognition .005 .108 .543 .950
Total language .204 .634 .435 .942
Visual-motor integration .054 .764 .749 .873
Speech production .889 .038 .592 .495
Reading skills .905 .504 .278 .502
Math skills .070 .936 .197 .355
Executive function .014 .269 .026 .256
Memory .139 .485 .439 .705
Fine motor skills .038 .529 .495 .971
1234 The Journal of Thoracic and Cardiovascular Surferences in central nervous system development related to
the type of CHD, differences in the physiologic effects of
the specific defect, or diagnosis-specific differences in
management. In addition, the association of genetic anom-
alies that include both CHD and ND dysfunction varies ac-
cording to the type of CHD. Microdeletions of the 22nd
chromosome are more commonly identified in patients
with TOF compared with TGA.17,18
In the present study, we evaluated outcomes for 8 ND do-
mains in preschool children after surgery in infancy for
TGA, VSD, TOF, and HLHS. We specifically excluded pa-
tients with known or suspected genetic anomalies. The
mean unadjusted outcomes for all domains in all 4 diagnos-
tic groups were within the normal range ( SD) for the gen-
eral population. However, the number of children with
moderate to severe impairment in at least 1 ND domain
was greater than expected for the general population for
all diagnostic groups. The differences among the diagnostic
groups were less than might be predicted from previous re-
search. In general, the mean scores for the patients with
HLHS tended to be lower than those for the other diagnostic
groups.16,19 These differences were significant for 4 of the 8
developmental domains evaluated. Unlike in previous
studies, no significant differences were found among the
patients with TGA, TOF, or VSD for unadjusted
outcomes for any domain. This finding might have been
secondary to careful evaluation for genetic syndromes and
exclusion of patients with known or suspected genetic
anomalies.17
Significant differences were found among the diagnostic
groups for several factors that might adversely affect ND
outcomes, including preoperative mechanical ventilation
and postoperative length of stay. As would be expected, at
least moderately strong correlations were found between
the cardiac diagnosis and several operative management
variables. In addition, unlike the other patient groups, the
patients with HLHS undergo multiple operations and re-
main hypoxemic until completion of the Fontan procedure,
usually between 2 and 3 years of age. These differences ingery c December 2010
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significantly linked to the specific cardiac diagnosis. After
correction for preoperative and operative factors, we could
no longer identify significant differences among the diag-
nostic groups for any ND domain.
We previously evaluated the outcomes for our patients
with HLHS at 1 year of age.5 In that report, we noted that
the mean scores for the Bayley Scales of Infant
Development-II were lower than those of the population
norms, and many children had scores more than 2 SD less
than the mean signifying severe impairment. We included
children with genetic anomalies in that analysis and pres-
ence of such an anomaly was a significant predictor of
worse performance. The present study included only chil-
dren with no evidence of genetic syndromes, which likely
explains the better performance for the HLHS subgroup.
The present study had limitations. The management of
CPB was not standardized for the present study. By the na-
ture of their defect, children with HLHS experience pro-
longed exposure to hypoxemia compared with children
with 2-ventricle CHD. However, we did not assess the se-
verity or duration of the hypoxemia. Although we evaluated
multiple ND domains, these might have provided an incom-
plete assessment of the potential developmental disabilities,
especially behavioral problems. In particular, the young age
of the children makes an assessment of academic abilities
difficult.
CONCLUSIONS
The mean scores for the ND domains tested were in the
normal range for preschool children with no recognized ge-
netic syndromes after surgery for VSD, TOF, TGA, or
HLHS. The number of children with moderate to severe im-
pairments in at least 1 domain was increased compared with
the general population for all diagnostic groups. The unad-
justed ND outcomes for those with HLHS were lower for
cognition, fine motor skills, executive function, and math
skills compared with the other patients. After correction
for the demographic, preoperative, and operative variables,
no significant differences were seen among the 4 groups for
any domain. The specific cardiac diagnosis determined
a large portion of the variation in these covariates. There-
fore, although HLHS did predict for poorer outcomes in
some domains, it did not add predictive power to the other
factors considered. From our results, it was not possible to
determine whether the cardiac diagnosis is causal in its pre-
diction of ND outcomes or related secondary to covariates.
Unlike previous studies, we found no significant differences
in ND outcomes among the patients with TGA, TOF, or
VSD. This likely resulted from our exclusion of patients
with suspected or confirmed genetic anomalies. This find-
ing highlights the importance of genetic factors as a determi-
nant of ND outcomes in the CHD population. Future studies
of ND outcomes or neuroprotective strategies in this popu-The Journal of Thoracic and Carlation should include formal genetic evaluation and stratifi-
cation by the presence of genetic anomalies.
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APPENDIX
The Wechsler Preschool and Primary Scale of Intelli-
gence, 3rd edition (WPPSI-III) is a standardized test of in-
telligence for children 3.5 to 7 years old.8 It is commonly
used in both clinical settings and research. It takes approx-
imately 45 minutes to administer and yields 3 summary
scores and 12 subtest scores. The scores include the full-
scale IQ, verbal IQ, and performance IQ, with a mean scorediovascular Surgery c Volume 140, Number 6 1235
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Dof 100 and standard deviation of 15 points. It covers a wide
range of cognitive tasks. A large body of data is available to
explain the meaning of the test findings. The WPPSI-
revised has been proved to have moderate to strong reliabil-
ity (the coefficient for verbal, performance, processing
speed, full and general language was 0.92, 0.87, 0.93,
0.92, and 0.90, respectively) and validity (correlation with
other cognitive tests in the positive and significant range
of 0.74-0.90) in a variety of studies.
The Preschool Language Test-4 is a general test of early
language skills.9 It provides a measure of language compre-
hension and expressive communication. The standard
scores are derived according to age and performance. The
total language score (mean 100, with a standard deviation
of 15) is derived according to performance on the receptive
and expressive sections.
The Developmental Test of Visual Motor Integration
(VMI) is a copying task used to assess a child’s fine motor
and visual motor coordination skills.11 It takes 10 minutes
to complete and yields standard scores with a mean of
100 and standard deviation of 15. It is a well-recognized
test, and the new edition was published in 1989. Handed-
ness is also noted on the VMI. The interrater reliability
had a median of 0.93. Generally, researchers have found
the VMI to be a valuable predictor when used in combina-
tion with other measures. The positive correlation with
other tests of visual skills and motor skills was documented
in the manual as ranging from 0.72 to 0.76.
The Goldman Fristoe Test of Articulation 2 (GFTA) is
a systematic measure of assessing an individual’s articula-
tion of the consonant sounds of Standard American English.
Scores are represented in percentiles according to age and
performance.12 The time for testing is 10 to 15 minutes.
The Woodcock-Johnson III is a standardized achieve-
ment test for children 2 years to adulthood. It has recently
been normed and revised.13 It has subtests that measure
achievement and cognitive skills. For the purpose of the
present study, only the reading and math clusters were
used. These subtests take about 10 minutes each and mea-
sure a preschooler’s skills in these areas. The norming pro-
cedures of the Woodcock-Johnson III were excellent and
reflected the most recent census data. The data on reliability
ranged from 0.80 to 0.87 for individual tests. This is one of
the few achievement tests that have been normed for pre-
schoolers.
The Neuro-PSYchology (NEPSY) statue test is a devel-
opmental neuropsychological assessment tool published
in 1998. Korkman and colleagues.10 The NEPSY Statue
subtest assesses inhibition and motor persistence. The
NEPSY subtests yield scale scores with a mean of 10 and
a standard deviation of 3. The reliability ranges from 0.50
to 0.81. The validity studies indicated a low correlation be-
tween the attention/executive function subtests and tests of
general intelligence. The use of the NEPSY with clinical1236 The Journal of Thoracic and Cardiovascular Surpopulations of children diagnosed with attention deficit hy-
peractivity disorder has shown that identified children score
significantly poorer on the tests of attention.
The Wide Range Assessment of Visual Motor Abilities
pegboard is a manipulative dexterity test.14 The child inserts
as many pegs as possible within 90 seconds using a nearly
square pegboard. The pegboard is ‘‘waffled’’ to add to its
fine motor demands, as well as to increase its esthetic ap-
peal. The test is completed first with the dominant hand
and then with the nondominant hand. This test was chosen
from the collection of pegboard tasks (e.g., the Purdue peg-
board and grooved pegboard), because it is the only one de-
signed and standardized for a 4-year-old population. The
scores are provided as standard scores and percentiles,
which were published in 1995. The reliability and validity
for the proposed age group are strong.Discussion
Dr Ivan M. Rebeyka (Edmonton, Alberta, Canada). Neurode-
velopmental outcome has now eclipsed mortality as the new yard-
stick or scorecard by which the results of congenital heart surgery
are presently evaluated and compared. Ten years ago, the referring
cardiologist seemed quite satisfied when the patient survived to
discharge; now, they expect them to be future candidates for mem-
bership in the Mensa Society.
Dr. Gaynor and colleagues at the Children’s Hospital of Phila-
delphia have been leaders in this area of investigation and have
made many contributions, including the demonstration that
much of the variance seen in developmental outcomes after con-
genital cardiac surgery is secondary to unmodifiable patient char-
acteristics related to a genetic predisposition and that the surgeon
no longer should feel guilty about every suboptimal outcome,
because it is not always their fault.
This report describes the neurodevelopmental outcomes of a co-
hort of 178 patients who had undergone repair before 6 months of
age and then underwent a detailed neurodevelopmental assessment
at 4 years of age. This type of study clearly represents a tremendous
amount of work and the results warrant careful study.
The results at first glance seem almost too good to be true, with
average unadjusted cognition scores ranging from 94 for those
with hypoplastic left heart syndrome to 105 for those with transpo-
sition. However, Dr Gaynor has also indicated that the study pa-
tients had been selected by excluding those with either a definite
or suspected genetic abnormality.
Thus, my first question relates to the total number of children
not included in the analysis. If I read the manuscript correctly,
381 patients had undergone the 4–year evaluation, but the results
for only 178 patients were included in the analysis, suggesting
that more than one half of the patients were excluded. Thus, al-
though a definite chromosomal abnormality such as trisomy 18
or 21 is obvious, the other classifications of a suspected genetic ab-
normality must have been more subjective. Therefore, I would ask
by what criteria the genetic dysmorphologist excluded those pa-
tients with a suspected genetic abnormality, because there really
seems to be a disproportionately high number of children with
genetic syndromes among these 4 diagnostic groups.gery c December 2010
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examination by the dysmorphologist. Also, many of the patients,
particularly in this group—most of the ones who had genetic syn-
dromes in this group were in the tetralogy group.Most of those had
confirmed microdeletions of the 22nd chromosome. A variety of
other defects were present in terms of translocations and other ge-
netic abnormalities we found on chromosomal testing and a variety
of other syndromes—Charge syndrome, Pierre Robin syndrome,
Kabuki syndrome—that were not picked up at birth.
When we set up this cohort, we specifically tried to exclude pa-
tients with any genetic syndrome; however, as we have demon-
strated, it can be very difficult to recognize dysmorphic features
in the newborn period because of the infant’s features. Thus, at 1
year of age, this was determined by the examination findings,
the presence of dysmorphic features, and the genetic testing rec-
ommended by our geneticist.
DrRebeyka. It just seems high that well over one half had some
type of genetic syndrome.
DrGaynor.Well, this was not all half. Again, becausewe specif-
ically wanted to compare specific cardiac diagnoses, we have
about—if you consider the whole cohort, we had about 20% or
20% to 25% who have a definite or suspected syndrome. We ex-
cluded many of the cardiac diagnoses; for example, 2 children with
an aortopulmonary window and a small numberwith every other de-
fect one can imagine, including anomalous left coronary, anomalous
pulmonary veins, truncus arteriosus, interrupted aortic arch. We ex-
cluded those patients because the subgroups in any particular group
were not enough to allow an analysis to study the cardiac defect and
the cardiac diagnosis, which was the purpose of this study.
Dr Rebeyka.My second question relates to the use of the mean
scores as a potentially misleading indicator of neurodevelopmental
outcome. One would be hard pressed not to be pleased with aver-
age scores of 95 for those with hypoplastic left heart syndrome,
104 for tetralogy, and a similar value of 104 for VSD, as your re-The Journal of Thoracic and Carsults indicate. However, considering the number of patients having
either amoderate or severe degree of impairment, the outcomes are
not quite so optimistic, as you pointed out, with 35% of those with
hypoplastic left heart syndrome having either moderate or severe
impairment, and corresponding percentages for those with tetral-
ogy and VSD of 29% and 23%. Although it might be understand-
able to observe this degree of impairment in the hypoplastic group,
it seems disturbing that 29% of those with tetralogy and 23% of
those with VSD had either a moderate or severe degree of impair-
ment. Can you comment on that?
Dr Gaynor. Particularly with those with VSD, we were sur-
prised at how poorly they did. But, again, you have to remember
this is, particularly for those with VSD, this is a subgroup. A tetral-
ogy of Fallot repair is usually done at 2 to 3 months of age at our
institution. These VSD cases were almost always selected because
they were children who had severe heart failure and failure to
thrive and, usually, suboptimal weight gain. If you looked at the
weights, the weights of the VSD patients were significantly less
than the weights of the tetralogy patients. I think, at least for the
VSD cases, I can understand that these children had had failure
to thrive and poor growth in the early postnatal period, which is
critical for brain development. So, I think this is not all patients
with VSD, this is patients with VSD who came to surgery very
early in life, usually at around 2 months of age, and almost always
because of failure to thrive.
In terms of those with tetralogy, I am not sure why they had that
degree of impairment.
Dr Rebeyka.My last question is a real easy one. Your series of
178 patients includes 67 with hypoplastic left heart syndrome and
25 with VSD. In Philadelphia, do you really perform 2.5 times as
many hypoplastic repairs as VSD repairs?
Dr Gaynor. Again, this is all patients younger than 6 months of
age; a lot of our VSD patients are older than 6 months of age. So
again, this is by specific entry criteria for this study.diovascular Surgery c Volume 140, Number 6 1237
